Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer. [electronic resource]
Producer: 20140716Description: 599-606 p. digitalISSN:- 1095-6859
- Animals
- Antineoplastic Agents -- pharmacology
- Carcinoma, Ovarian Epithelial
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- DNA Damage -- drug effects
- DNA, Neoplasm -- drug effects
- Down-Regulation
- Drug Resistance, Neoplasm
- Drug Synergism
- Female
- Histone Deacetylase Inhibitors -- pharmacology
- Humans
- Hydroxamic Acids -- pharmacology
- Mice
- Mice, Nude
- Neoplasms, Glandular and Epithelial -- genetics
- Ovarian Neoplasms -- genetics
- Phthalazines -- pharmacology
- Piperazines -- pharmacology
- Recombinational DNA Repair -- drug effects
- Tissue Array Analysis
- Vorinostat
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.